Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Clinical Randomized Controlled Trial on the Efficacy and Safety of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis

NCT07115641 is registered in ClinicalTrials.gov with Wangjing Hospital, China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT07115641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07115641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Clinical Randomized Controlled Trial on the Efficacy and Safety of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis
Lead sponsor
Wangjing Hospital, China Academy of Chinese Medical Sciences
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 11, 2025
Completion date
August 31, 2026
Enrollment
240 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis